| Dr Stephanie Vampola-runyan, DO | |
|
515 Pacific Ave, Audubon, IA 50025-1056 | |
| (712) 563-4611 | |
| (563) 742-4355 |
| Full Name | Dr Stephanie Vampola-runyan |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 515 Pacific Ave, Audubon, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891101457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R-10154 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carroll Area Nursing Services | Carroll, IA | Home health agency |
| Guthrie County Phns | Guthrie center, IA | Home health agency |
| Kindred Hospice | Carroll, IA | Hospice |
| Hospice Of The Midwest, Llc | Johnston, IA | Hospice |
| Audubon County Memorial Hospital | Audubon, IA | Hospital |
| St Anthony Regional Hospital & Nursing Home | Carroll, IA | Hospital |
| Cass County Memorial Hospital | Atlantic, IA | Hospital |
| Exira Care Center | Exira, IA | Nursing home |
| Friendship Home Association | Audubon, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Audubon County Memorial Hospital | 7618866096 | 15 |
News Archive
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed the dose escalation stage of an ongoing Phase II study of CD-NP in patients with acute decompensated heart failure. Nile had previously announced that the study, NIL-CDNP-CT005, was expanded to permit additional dose exploration prior to proceeding to larger Phase II studies.
APOSEC it is a biologic wound-healing agent developed by thoracic surgeon Hendrik Jan Ankersmit from MedUni Vienna.
Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the start of the TREVO Study. The first patients were enrolled and successfully treated at the Hospital Clinic de Barcelona by the Neuroradiology team of Drs. Juan Macho and Jordi Blasco.
› Verified 4 days ago
| Entity Name | Audubon County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730153420 PECOS PAC ID: 7618866096 Enrollment ID: O20040312001260 |
News Archive
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed the dose escalation stage of an ongoing Phase II study of CD-NP in patients with acute decompensated heart failure. Nile had previously announced that the study, NIL-CDNP-CT005, was expanded to permit additional dose exploration prior to proceeding to larger Phase II studies.
APOSEC it is a biologic wound-healing agent developed by thoracic surgeon Hendrik Jan Ankersmit from MedUni Vienna.
Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the start of the TREVO Study. The first patients were enrolled and successfully treated at the Hospital Clinic de Barcelona by the Neuroradiology team of Drs. Juan Macho and Jordi Blasco.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Vampola-runyan, DO 515 Pacific Ave, Audubon, IA 50025-1056 Ph: (712) 563-4611 | Dr Stephanie Vampola-runyan, DO 515 Pacific Ave, Audubon, IA 50025-1056 Ph: (712) 563-4611 |
News Archive
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed the dose escalation stage of an ongoing Phase II study of CD-NP in patients with acute decompensated heart failure. Nile had previously announced that the study, NIL-CDNP-CT005, was expanded to permit additional dose exploration prior to proceeding to larger Phase II studies.
APOSEC it is a biologic wound-healing agent developed by thoracic surgeon Hendrik Jan Ankersmit from MedUni Vienna.
Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the start of the TREVO Study. The first patients were enrolled and successfully treated at the Hospital Clinic de Barcelona by the Neuroradiology team of Drs. Juan Macho and Jordi Blasco.
› Verified 4 days ago
Terry L Sprague, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 Broadway, Audubon Medical Clinic, Audubon, IA 50025 Phone: 712-563-4206 Fax: 712-563-2001 | |
Charles Ryan Burkett, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Pacific Ave Ste 2, Audubon, IA 50025 Phone: 712-563-4611 Fax: 412-563-2498 | |
James Michael Cunningham, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 Pacific Ave Ste 2, Audubon, IA 50025 Phone: 712-563-4611 Fax: 712-563-2498 |